Search

everythinglearnresearchcommunity

for

Search:↓

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Antiandrogen therapy may help treat hidradenitis suppurativa.

Women with PCOS have lower zinc levels.

The Cyp11a1 gene variation has a weak link to PCOS, but higher di-hydro-testosterone levels are found in PCOS patients.

Taking Vitamin D with clomiphene citrate significantly improves ovulation in women with Poly Cystic Ovary Syndrome.

Vitamin D supplements increased ovulation rates in women with PCOS who were vitamin D deficient.

Silymarin and metformin together most improved hormone levels and ovulation in women with PCOS.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Adult women with acne in Iraq often have more severe symptoms and hormone-related issues than younger girls with acne.

High levels of Anti-Müllerian Hormone (AMH) in the blood can strongly predict Polycystic Ovarian Syndrome (PCOS) and related issues in women of reproductive age.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Women with PCOS have a higher risk of heart disease.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Calculated testosterone values are reliable for assessing hyperandrogenemia in women, making direct measurement unnecessary.